|
Oct 14
|
Iridium Gearing Up to Report Q3 Earnings: Here's What to Expect
|
|
Oct 14
|
Abbott's Q3 Earnings Release Coming Up, EPD Business in Focus
|
|
Oct 14
|
What to Expect From Badger Meter Stock Ahead of its Q3 Earnings
|
|
Oct 11
|
Abbott advances two pulsed field ablation studies for AFib treatment
|
|
Oct 11
|
Stocks to watch next week: Netflix, LVMH, ASML, Rio Tinto and Goldman Sachs
|
|
Oct 11
|
Abbott (ABT) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
|
|
Oct 11
|
Abbott enrolls pivotal PFA study 4 months ahead of schedule
|
|
Oct 11
|
Abbott Laboratories' (NYSE:ABT) five-year earnings growth trails the respectable shareholder returns
|
|
Oct 10
|
Abbott Advances Pulsed Field Ablation Clinical Studies and Launches New Technology to Support Advanced Cardiac Mapping
|
|
Oct 9
|
Abbott (ABT) Earnings Expected to Grow: Should You Buy?
|
|
Oct 9
|
Abbott price target raised to $130 from $125 at RBC Capital
|
|
Oct 8
|
Why Abbott (ABT) Outpaced the Stock Market Today
|
|
Oct 7
|
Abbott Laboratories (NYSE:ABT) is favoured by institutional owners who hold 77% of the company
|
|
Oct 5
|
Abbott Laboratories (ABT): A Buzzing AI Health Stock to Add to Your Portfolio
|
|
Oct 5
|
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades
|
|
Oct 4
|
PAHC or ABT: Which Is the Better Value Stock Right Now?
|
|
Oct 3
|
Abbott Laboratories Insiders Sold US$7.7m Of Shares Suggesting Hesitancy
|
|
Oct 2
|
Abbott (ABT) Outperforms Broader Market: What You Need to Know
|
|
Oct 2
|
Abbott price target raised to $124 from $120 at Evercore ISI
|
|
Oct 2
|
Down More Than 50%, Is DexCom Stock a Bargain Now?
|